<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Stadler BM</dc:creator>
  <dc:creator>Rudolf MP</dc:creator>
  <dc:creator>Zürcher AW</dc:creator>
  <dc:creator>Miescher S</dc:creator>
  <dc:creator>Vogel M</dc:creator>
  <dc:date>1996</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Anti-IgE autoantibodies exist predominantly in the sera of patients with atopic disease. For some time such anti-IgE autoantibodies have been considered a phenomenon that may not be of clinical importance. The cloning of such anti-IgE autoantibodies has eliminated doubts of whether these antibodies exist, but it is still unclear whether such autoantibodies play a pathophysiological role. However, there are ongoing clinical trials that use humanized anti-IgE antibodies for passive immunization of atopic individuals. While this approach may not definitely clarify the role of anti-IgE autoantibodies, it will nevertheless clarify the role of IgE.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/63669</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1038/icb.1996.27</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/8724009</dc:relation>
  <dc:source>Immunology and cell biology. - 1996</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Animals</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Antibodies, Monoclonal</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Autoantibodies</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Cloning, Molecular</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Hypersensitivity, Immediate</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Immunization</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Immunoglobulin E</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Vaccines</dc:subject>
  <dc:title xmlns:ns10="xml" ns10:lang="en">Anti-IgE in allergic sensitization.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
